| ||
| ||
| Clinic Roundup Behavioral Health Central ... study of CDX-011 (glembatumumab vedotin), an antibody drug conjugate, in patients with glycoprotein NMB-expressing advanced, refractory breast cancer. ... See all stories on this topic » | ||
| User Name Password Sign In Annals of Internal Medicine I am labeled a breast cancer survivor. I am not a "language person," so I don't pay much attention to exact meanings of words and all of their permutations. ... See all stories on this topic » | ||
| Peregrine Provides Update On Government-Sponsored Research BioResearch Online (press release) ... currently in two Phase IIb clinical trials for non-small cell lung cancer (NSCLC), three Phase II clinical trials in NSCLC and advanced breast cancer, ... See all stories on this topic » |
This as-it-happens Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment